Results 211 to 220 of about 26,689 (268)
The world apheresis association registry, 2023 update
Transfusion and Apheresis Science, 2023 The WAA apheresis registry contains data on more than 140,000 apheresis procedures conducted in 12 different countries. The aim is to give an update of indications, type and number of procedures and adverse events (AEs).
Volker Witt
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The International Journal of Artificial Organs, 1995
Treatment of hemophilia patients with inhibitors is most effective if circulating levels of factor VIII (F.VIII) or factor IX (F.IX) can be obtained. This is possible not only in patients with low inhibitor concentration, but also in those with high inhibitor levels after temporary removal of the inhibitors by means of apheresis methods.
I M, Nilsson, C, Freiburghaus
openaire +3 more sources
Treatment of hemophilia patients with inhibitors is most effective if circulating levels of factor VIII (F.VIII) or factor IX (F.IX) can be obtained. This is possible not only in patients with low inhibitor concentration, but also in those with high inhibitor levels after temporary removal of the inhibitors by means of apheresis methods.
I M, Nilsson, C, Freiburghaus
openaire +3 more sources
Rheumatic Disease Clinics of North America, 2000
The removal of pathologic humors by various methods is an ancient medical remedy used in the management of diseases whose pathophysiology is poorly understood and whose effective treatment modalities are lacking. The contemporary means for such an approach involves apheresis, which is now possible due to advances in blood banking technologies ...
G G, Illei, J H, Klippel
openaire +3 more sources
The removal of pathologic humors by various methods is an ancient medical remedy used in the management of diseases whose pathophysiology is poorly understood and whose effective treatment modalities are lacking. The contemporary means for such an approach involves apheresis, which is now possible due to advances in blood banking technologies ...
G G, Illei, J H, Klippel
openaire +3 more sources
Endocrinology and Metabolism Clinics of North America, 2015
Patients with familial hypercholesterolemia (FH) have early development of atherosclerosis and cardiovascular disease (CVD). Lipid level-lowering medications are not always successful in reducing increased low-density lipoprotein C (LDL-C) levels. Lipoprotein apheresis (LA) therapy has proven its clinical benefit in reducing CVD events for patients ...
Patrick M, Moriarty, Linda, Hemphill
openaire +5 more sources
Patients with familial hypercholesterolemia (FH) have early development of atherosclerosis and cardiovascular disease (CVD). Lipid level-lowering medications are not always successful in reducing increased low-density lipoprotein C (LDL-C) levels. Lipoprotein apheresis (LA) therapy has proven its clinical benefit in reducing CVD events for patients ...
Patrick M, Moriarty, Linda, Hemphill
openaire +5 more sources
Transfusion and Apheresis Science, 2023
Mathematics is related to apheresis medicine. The safety of donor and patient in taking blood components is utterly important. Knowledge of total blood and plasma volume is needed and have to be calculated. By increasing quality, the safety of not only the donor and patient, but also the operator will increase, as well as the efficiency of operating an
Linda, Tjoelker +2 more
openaire +2 more sources
Mathematics is related to apheresis medicine. The safety of donor and patient in taking blood components is utterly important. Knowledge of total blood and plasma volume is needed and have to be calculated. By increasing quality, the safety of not only the donor and patient, but also the operator will increase, as well as the efficiency of operating an
Linda, Tjoelker +2 more
openaire +2 more sources
Journal of Clinical Apheresis, 2016 The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating, and categorizing indications for the evidence-based use of therapeutic apheresis in human disease.
Yanyun Wu +2 more
exaly +2 more sources
Journal of Clinical Apheresis, 2013 The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is charged with reviewing, updating and categorizating indications for therapeutic apheresis.
Yanyun Wu +2 more
exaly +2 more sources
Current Opinion in Lipidology, 2016
Purpose of review Currently, different methods for extracorporeal elimination of atherogenic apolipoprotein B100 containing lipoprotein particles are used in clinical practice. Most of them effectively remove both lipoprotein(a) [Lp(a)] and LDL.
Sergei N, Pokrovsky +2 more
openaire +2 more sources
Purpose of review Currently, different methods for extracorporeal elimination of atherogenic apolipoprotein B100 containing lipoprotein particles are used in clinical practice. Most of them effectively remove both lipoprotein(a) [Lp(a)] and LDL.
Sergei N, Pokrovsky +2 more
openaire +2 more sources
Atherosclerosis, 2003
Low density lipoprotein (LDL) apheresis provides a safe and effective means of treating patients with homozygous familial hypercholesterolaemia (FH). It also has a role in preventing the progression of coronary artery disease in heterozygotes and others with severe dyslipidaemia who are refractory to or intolerant of high doses of lipid-lowering drugs.
openaire +2 more sources
Low density lipoprotein (LDL) apheresis provides a safe and effective means of treating patients with homozygous familial hypercholesterolaemia (FH). It also has a role in preventing the progression of coronary artery disease in heterozygotes and others with severe dyslipidaemia who are refractory to or intolerant of high doses of lipid-lowering drugs.
openaire +2 more sources
Nursing, 2008
Find out about the many types and applications of this blood component-separating therapy.
openaire +2 more sources
Find out about the many types and applications of this blood component-separating therapy.
openaire +2 more sources